Cervomed Stock Analysis

CRVO Stock   15.32  0.93  5.72%   
CervoMed is fairly valued with Real Value of 15.47 and Target Price of 17.0. The main objective of CervoMed stock analysis is to determine its intrinsic value, which is an estimate of what CervoMed is worth, separate from its market price. There are two main types of CervoMed's stock analysis: fundamental analysis and technical analysis.
The CervoMed stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. CervoMed is usually not traded on Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day, Labour Day, Thanksgiving Day, Christmas Day, New Year 's Day, Dr . Martin Luther King Jr 's Birthday. CervoMed Stock trading window is adjusted to America/New York timezone.
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in CervoMed. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.
To learn how to invest in CervoMed Stock, please use our How to Invest in CervoMed guide.

CervoMed Stock Analysis Notes

About 35.0% of the company shares are held by company insiders. The company recorded a loss per share of 0.2. CervoMed last dividend was issued on the 14th of December 2018. The entity had 2:3 split on the 17th of August 2023. For more info on CervoMed please contact John MD at 617 744 4400 or go to https://www.cervomed.com.

CervoMed Investment Alerts

CervoMed generated a negative expected return over the last 90 days
CervoMed has high historical volatility and very poor performance
CervoMed was previously known as Diffusion Pharmaceuticals and was traded on NASDAQ Exchange under the symbol DFFN.
Net Loss for the year was (2.17 M) with profit before overhead, payroll, taxes, and interest of 0.
CervoMed generates negative cash flow from operations
CervoMed has a very weak financial position based on the latest SEC disclosures
About 35.0% of the company shares are held by company insiders
Latest headline from finance.yahoo.com: CervoMed to Participate in the Emerging Growth Conference

CervoMed Upcoming and Recent Events

Earnings reports are used by CervoMed to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period..
12th of February 2024
Upcoming Quarterly Report
View
31st of December 2023
Next Fiscal Quarter End
View
12th of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

CervoMed Largest EPS Surprises

Earnings surprises can significantly impact CervoMed's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2024-02-26
2023-12-31-0.29-0.38-0.0931 
2023-11-13
2023-09-30-0.95-0.70.2526 
2018-04-03
2018-03-31-0.040.380.421050 
View All Earnings Estimates

CervoMed Market Capitalization

The company currently falls under 'Small-Cap' category with a current market capitalization of 165.07 M.

CervoMed Profitablity

The company has Profit Margin (PM) of (0.51) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (1.11) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $1.11.

Management Efficiency

CervoMed has return on total asset (ROA) of (0.9048) % which means that it has lost $0.9048 on every $100 spent on assets. This is way below average. CervoMed's management efficiency ratios could be used to measure how well CervoMed manages its routine affairs as well as how well it operates its assets and liabilities. As of the 23rd of July 2024, Total Assets is likely to grow to about 19.6 M, while Non Current Assets Total are likely to drop 7,382.
The analysis of CervoMed's management efficiency is an essential part of evaluating and assessing the financial and operational performance of the entity. It is also vital to analyze CervoMed's future growth prospects and the overall market conditions to determine the value and potential of its stock. The analysis involves studying a range of financial metrics such as revenue, earnings, profit margins, cash flow, debt, market share, and external factors such as economic trends, industry outlook, competition, and government regulations. The goal of CervoMed Stock analysis is to determine whether it is undervalued, fairly valued, or overvalued and to make informed investment decisions.
Operating Margin
(1.11)
Profit Margin
(0.51)
Return On Assets
(0.90)

Technical Drivers

As of the 23rd of July, CervoMed shows the Mean Deviation of 2.96, standard deviation of 4.57, and Risk Adjusted Performance of (0.07). CervoMed technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.

CervoMed Price Movement Analysis

The output start index for this execution was two with a total number of output elements of fifty-nine. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. CervoMed middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for CervoMed. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.

CervoMed Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific CervoMed insiders, such as employees or executives, is commonly permitted as long as it does not rely on CervoMed's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases CervoMed insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

CervoMed Predictive Daily Indicators

CervoMed intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of CervoMed stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

CervoMed Corporate Filings

8K
12th of July 2024
Report filed with the SEC to announce major events that shareholders should know about
ViewVerify
8K
14th of June 2024
Report filed with the SEC to announce major events that shareholders should know about
ViewVerify
6th of June 2024
Other Reports
ViewVerify
30th of May 2024
Other Reports
ViewVerify
8K
20th of May 2024
Report filed with the SEC to announce major events that shareholders should know about
ViewVerify
8K
15th of May 2024
Report filed with the SEC to announce major events that shareholders should know about
ViewVerify
10Q
14th of May 2024
Quarterly performance report mandated by Securities and Exchange Commission (SEC), to be filed by publicly traded corporations
ViewVerify
S1
10th of May 2024
Report filed by companies planning on going public to register their securities with the U.S. Securities and Exchange Commission (SEC)
ViewVerify

CervoMed Forecast Models

CervoMed's time-series forecasting models are one of many CervoMed's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary CervoMed's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

About CervoMed Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how CervoMed prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling CervoMed shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as CervoMed. By using and applying CervoMed Stock analysis, traders can create a robust methodology for identifying CervoMed entry and exit points for their positions.
CervoMed is entity of United States. It is traded as Stock on NASDAQ exchange.

Current CervoMed Analysis - Recommendations

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. CervoMed analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. CervoMed analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target PriceAdvice# of Analysts
17.0Strong Buy3Odds
CervoMed current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most CervoMed analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand CervoMed stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of CervoMed, talking to its executives and customers, or listening to CervoMed conference calls.
CervoMed Analyst Advice Details

CervoMed Stock Analysis Indicators

CervoMed stock analysis indicators help investors evaluate how CervoMed stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading CervoMed shares will generate the highest return on investment. By understating and applying CervoMed stock analysis, traders can identify CervoMed position entry and exit signals to maximize returns.
Begin Period Cash Flow4.1 M
Common Stock Shares Outstanding5.7 M
Total Stockholder Equity7.4 M
Cash7.8 M
Accounts Payable662.5 K
50 Day M A22.8048
Total Current Liabilities2.6 M
Non Current Assets Total7770.00
Non Currrent Assets Other7770.00
Stock Based Compensation407.6 K

Additional Information and Resources on Investing in CervoMed Stock

When determining whether CervoMed offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of CervoMed's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Cervomed Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Cervomed Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in CervoMed. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.
To learn how to invest in CervoMed Stock, please use our How to Invest in CervoMed guide.
You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of CervoMed. If investors know CervoMed will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about CervoMed listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.20)
Revenue Per Share
1.984
Quarterly Revenue Growth
0.667
Return On Assets
(0.90)
The market value of CervoMed is measured differently than its book value, which is the value of CervoMed that is recorded on the company's balance sheet. Investors also form their own opinion of CervoMed's value that differs from its market value or its book value, called intrinsic value, which is CervoMed's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because CervoMed's market value can be influenced by many factors that don't directly affect CervoMed's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between CervoMed's value and its price as these two are different measures arrived at by different means. Investors typically determine if CervoMed is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, CervoMed's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.